Lilly Cuts Zepbound Price To Combat Cheaper Alternatives
To fight cheaper alternative versions of its weight loss drug, Eli Lilly & Co. have lowered prices of Zepbound vials.
Read MoreTag Archives: Wegovy
Lilly’s Zepbound Superior To Wegovy In Head-To-Head Trial
Eli Lilly and Company has announced topline results from the SURMOUNT-5 phase 3b open-label randomized clinical trial.
Read More
Lilly Shares Drop After Roche Announces Result Of Obesity Drug
Shares of Eli Lilly and Co. took a two-day slide after competitor Roche announced positive results in an early-stage study on its obesity drug.
Read More